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UXT chaperone prevents proteotoxicity by acting
as an autophagy adaptor for p62-dependent
aggrephagy
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p62/SQSTM1 is known to act as a key mediator in the selective autophagy of protein
aggregates, or aggrephagy, by steering ubiquitinated protein aggregates towards the
autophagy pathway. Here, we use a yeast two-hybrid screen to identify the prefoldin-like
chaperone UXT as an interacting protein of p62. We show that UXT can bind to protein
aggregates as well as the LB domain of p62, and, possibly by forming an oligomer, increase
p62 clustering for its efficient targeting to protein aggregates, thereby promoting the
formation of the p62 body and clearance of its cargo via autophagy. We also find that ectopic
expression of human UXT delays SOD1(A4V)-induced degeneration of motor neurons in a
Xenopus model system, and that specific disruption of the interaction between UXT and
p62 suppresses UXT-mediated protection. Together, these results indicate that UXT
functions as an autophagy adaptor of p62-dependent aggrephagy. Furthermore, our study
illustrates a cooperative relationship between molecular chaperones and the aggrephagy
machinery that efficiently removes misfolded protein aggregates.
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Newly synthesized proteins must go through a process thatensures proper folding, and this phenomenon is hamperedby mutations, oxidative stress, or transcriptional/transla-
tional errors1. Misfolding of a protein often leads to the exposure
of the hydrophobic regions that would otherwise be internally
buried, and consequently, protein aggregation. Accumulation of
protein aggregates ultimately results in cellular toxicity that
postmitotic cells such as neurons are more vulnerable to. For
example, protein aggregates containing amyloid-beta, huntingtin,
and mutant form of superoxide dismutase 1 (SOD1) are respec-
tively associated with neurodegenerative diseases, such as Alz-
heimer’s disease2,3, Huntington’s disease4–6, and a form of familial
amyotrophic lateral sclerosis (ALS)3,7. The ubiquitin–proteasome
system (UPS) and autophagy–lysosomal system are the two major
surveillance systems that cooperatively detect and remove mis-
folded proteins8. The UPS recognizes and ubiquitinates the
hydrophobic residues on the surface of misfolded proteins by
ubiquitin ligases with the aid of molecular chaperones9–11. When
the UPS is impaired or overloaded, misfolded proteins accumulate
and often form intracellular aggregates that are then directed
toward the alternative autophagy pathway12,13.
During aggrephagy, or the selective degradation of protein
aggregates by autophagy, protein aggregates are recognized by
various autophagy receptors, which deliver them to the phago-
phore (the forming autophagosome)14–16. A well-known receptor
for autophagy, p62 (also known as sequestosome-1), sequesters
protein aggregates in condensates called the p62 body before
eventually targeting them to the phagophore for proteolytic
degradation15,17,18. As its role suggests, p62 contains multiple
domains that are required for its interaction with proteins in
diverse pathways (Fig. 1a). The N-terminal PB1 domain mediates
homo-oligomerization that facilitates p62 body formation, and
may increase its affinity for protein aggregates and/or the
phagophore18,19. The C-terminal ubiquitin-associated (UBA)
domain interacts with ubiquitinated protein aggregates15,20 and
the LC3-interacting region motif directly binds to Atg8/LC3 on
the phagophore surface17, thereby linking the protein aggregates
to the phagophore membrane to form the autophagosome17,21. A
pioneering study established the importance of PB1 and UBA
domains in autophagy15 by showing that a p62 deletion mutant
that only contained PB1 and UBA domains can induce p62 body
formation. The Keap interaction region domain mediates Keap1
binding when phosphorylated at Ser349 residue, releasing a
transcription factor Nrf2 from Keap1 to control the gene
expression22 and/or modulating p62 activity by ubiquitination23.
In contrast, although new proteins that regulate p62 function and
interact with the zinc finger ZZ domain, LIM protein-binding
domain (LB), and TRAF6-binding domain have recently been
identified, the roles of these domains in p62-mediated autophagy
remain relatively unclear24–26.
In this study, we used an unbiased yeast two-hybrid approach
to identify a possible regulator of p62 that binds to those not-
well-characterized regions and identified UXT, a 157 amino acid
long protein known to be ubiquitously expressed in various
tissues27, as a protein binding to the LB domain of p62. Among
several functions of UXT suggested so far, including a cofactor of
nuclear receptors28,29, a regulator of NF-κB signaling30, and a
prefoldin-like molecular chaperone30, we focused on its possible
function as the chaperone. Prefoldin is a jellyfish-like hexameric
chaperon31 preventing protein aggregates found in various neu-
rological diseases32–34, presumably by delivering the aggregate-
prone proteins to chaperonins, such as TRiC35. In an analogy to
the function of prefoldin, we hypothesized that UXT may have a
similar but distinct role, delivering protein aggregates to autop-
hagy machinery by interacting with p62. Here, we show that
UXT, presumably by forming an oligomeric form, can associate
with protein aggregates to enhance p62 body formation. This
results in efficient clearance of the p62 cargo by autophagy and
amelioration of loss of motor function associated with an animal
model of ALS in a p62-dependent manner. Based on these results,
we propose that UXT may serve as a potential therapeutic target
for drugs aimed at treating neurodegenerative diseases associated
with protein aggregation, including ALS.
Results
A p62 interacting protein UXT colocalizes with protein
aggregates. The formation of p62 bodies, characterized by clear
punctate structures that colocalize with aggregates, is thought to
be dependent on the interaction between ubiquitinated protein
aggregates and the UBA domain of p62, as well as PB1 domain-
mediated oligomerization of p62 (ref. 15). However, when a p62
mutant p62(ΔZZ–LB), lacking domains seemingly nonessential
for p62 body formation, i.e., ZZ and LB domains (Fig. 1a), was
transiently transfected for testing its ability to form the p62 body
in p62 knockout HeLa cells (HeLa/p62KO; Supplementary
Fig. 1a–e), we observed that p62 body formation by the mutant is
not as efficient as that by wild type (WT): the p62 bodies formed
by the mutant were smaller in size and number compared to
those formed by the WT protein (Fig. 1b). For quantitative
analysis of p62 body formation, we developed an in-house
MATLAB code (Supplementary Code 1) that automatically
selects pixels with fluorescence intensities exceeding three stan-
dard deviations of the mean of whole-cell intensity as regions of
p62 bodies. It was also able to calculate a clustering index, defined
as the sum of fluorescence intensity of p62 staining in the selected
cell, divided by the mean of whole-cell fluorescence intensity
(Supplementary Fig. 2a, b). In this unbiased analysis, the mutant
p62 had a significantly lower clustering index than the WT
(Fig. 1c). Consistently, the mutation also led to decrease in the
number and size of p62 bodies (Supplementary Fig. 2c, d), sug-
gesting that these domains may contribute to p62 body forma-
tion. HeLa/p62KO cells stably transfected with p62(ΔZZ–LB) also
showed the similar defect (Supplementary Fig. 2e–h). Interest-
ingly, a previous study had reported that p62 mutant lacking
exons 4 and 5 do not bind to SOD1(A4V) associated with familiar
ALS36. As the exons 3 through 5 encode the ZZ and LB domains,
this is consistent with our findings and is also additional evidence
that shows the importance of these domains in p62 body for-
mation. To gain a mechanistic understanding of the function of
these two domains, we performed yeast two-hybrid screens using
the ZZ and LB domains as bait (Fig. 1a). In this screen, we found
that 9 out of 27 URA3 and ADE2 reporter-positive clones were
UXT (Supplementary Table 1). Notably, while most other URA3
and ADE2-positive clones were negative for the lacZ reporter
assay, the UXT clones that were identified were positive (Fig. 1d
and Supplementary Table 1), demonstrating their relatively
strong affinity for p62. HA-tagged p62 and GFP-tagged UXT
transiently expressed in HEK239T cells (Fig. 1e), as well as
endogenous p62 and UXT in HeLa cells (Supplementary Fig. 2i)
also co-immunoprecipitated, validating the interaction. A proxi-
mity ligation assay (PLA) also showed an interaction between
endogenously expressed p62 and UXT in HeLa cells (Fig. 1f, g).
We subsequently used p62 deletion mutants to map the region
required for UXT binding to the LB domain (Fig. 1h and Sup-
plementary Fig. 2j), especially from 184th to 204th residues
(Fig. 1i, j and Supplementary Fig. 2k). The better binding of UXT
to the ΔZZ mutant than to the WT (Fig. 1j) suggests that the
neighboring ZZ domain may sterically hinder the interaction. To
determine if UXT is involved in p62-mediated autophagy, we
first utilized HeLa cells stably expressing the well-known aggre-
gate-prone cystic fibrosis transmembrane conductance regulator
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(CFTR) mutant CFTR(ΔF508)37,38, and checked for colocaliza-
tion of the CFTR aggregates with UXT and p62. As the UPS is
responsible for degradation of the misfolded CFTR protein38,
inhibition of UPS by MG132 treatment increased accumulation of
CFTR aggregates (Fig. 1k). In the aggregates, we could detect both
p62 as well as UXT (Fig. 1k), suggesting that interaction between
p62 and UXT may play a role in protein aggregates. The targeting
of UXT to protein aggregates upon MG132 treatment was also
confirmed by increased UXT levels in the protein aggregates
containing detergent-insoluble fraction, in which increase of
autophagic machinery, p62 and phosphatidylethanolamine (PE)-
conjugated LC3 form (LC3-II)39, was observed (Fig. 1l, bottom).
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Notably, the levels of total UXT protein were also increased in
MG132-treated cells (Fig. 1l, top), suggesting that UXT may play
a role in conditions with increased misfolded protein aggregates.
UXT overexpression protects DRG neurons from proteasome
inhibition-induced cell death. Colocalization of UXT with pro-
tein aggregates led us to propose that UXT may have a role in the
handling of protein aggregates. As neuronal cells are known to be
more vulnerable than other types of cells to protein aggregates40,
we tested the effect of UXT on protein aggregation condition in
primary dorsal root ganglion (DRG) neurons. We found that
UXT colocalizes with p62 bodies in DRG neurons, and as
expected, proteasome inhibition by MG132 treatment increased
p62 body formation (Fig. 2a). This was similar to what we
observed in HeLa cells, most p62 bodies colocalized with protein
aggregates stained with anti-ubiquitin (Fig. 2a, upper panels) and
with UXT (Fig. 2a, lower panels). We next investigated the
consequences of proteasome inhibition in DRG neurons and the
effect of increased expression of UXT in the process. To this end,
we transduced DRG neurons with lentivirus bearing mCherry-
fused UXT or mCherry control, treated them with MG132, and
observed neurons over time under a fluorescence microscope
equipped with temperature and humidity controllers (Fig. 2b). At
~8 h after 2.5 µM MG132 treatment, cell bodies of the DRG
neurons started to shrink first and generates blebs that eventually
burst within ~2.5 h after the first appearance of blebbing (Fig. 2c
and Supplementary Movie 1a, b). The cells showed blebbing in
the real-time observation was also specifically stained with anti-
cleaved caspase-3 (Supplementary Movie 1c), an apoptosis
marker41, suggesting that the cell death may be mediated by
apoptosis. As such, we used bursting as a marker of cell death to
study survival. We found that DRG neurons transduced with
UXT were more resistant to MG132-induced toxicity than control
DRG neurons, with 50% cell death observed at 1600 and 900 min,
respectively, after MG132 treatment (Fig. 2d). No cell death was
observed within the same time window for the untreated control
(Fig. 2d, blue line), indicating that cell death observed was due to
MG132-induced toxicity. Together, these results suggest that
UXT may exert protective functions against protein aggregate-
induced neuronal cell death.
UXT cooperates with p62 during autophagy. As UXT directly
interacts with the autophagy receptor p62, we hypothesized that
the protective effect of UXT can be attributed at least in part to
p62-dependent autophagy. Indeed, when autophagy was blocked
using an autophagic flux inhibitor (Fig. 3a, b), bafilomycin A142,
or transient p62 knockdown (Fig. 3c), the accumulation of UXT
protein was observed (Fig. 3a, b), suggesting its possible invol-
vement in p62-dependent autophagy. Blocking UPS by MG132—
which increased the UXT protein level (Figs. 1l and 3a)—in this
background further enhanced UXT protein accumulation
(Fig. 3a). As we did not detect significant differences in UXT
mRNA levels under these treatment conditions by quantitative
reverse transcription polymerase chain reaction (RT-PCR; Sup-
plementary Fig. 3a), the increase in UXT protein levels does not
appear to be due to increase in mRNA expression. Instead, the
accumulation of UXT protein with MG132 treatment suggests
that UXT is constitutively degraded by UPS, but stabilized under
an aggregation-prone condition by an unidentified mechanism
for its possible roles in autophagy. To test this hypothesis, we
investigated if UXT is recruited to the autophagosome. When
autophagy was induced using amino acid deprivation along with
inhibition of autophagic flux in HeLa cells that stably expressed
GFP-LC3, we observed an increase in the number of puncta
positive for LC3 and p62 (Fig. 3d), which are the markers of
autophagosomes42. The number of UXT puncta with higher
fluorescence intensity was also increased in cells, in which
autophagy was induced compared to that in untreated control
cells (Fig. 3d). Under the autophagy-induced conditions, most of
the UXT-positive puncta colocalized with p62, and some of the
UXT- and p62-positive puncta also colocalized with LC3
(Fig. 3d), suggesting that UXT in combination with p62 can be
targeted to the phagophore. Quantification by using Pearson’s
correlation coefficient showed a significant increase in the colo-
calization within UXT, p62, and LC3 (Fig. 3e and Supplementary
Fig. 3b). Moreover, when we attempted to purify UXT (UXT-
eYFP-10×His) expressed in HEK293E cells by sequential Ni-NTA
and size-exclusion chromatography (SEC; Fig. 3f), we could see
the UXT-containing fractions observed near the column void
volume as a large complex contain various binders (Fig. 3g) of
which we could detected p62 and, based on the molecular weight,
LC3-II by western blots (Fig. 3h), suggesting UXT’s ability to
autophagosome targeting.
UXT mediates the clearance of aggregates via autophagy. As
UXT appeared to be targeted to the LC3-positive autophago-
somes, we investigated if UXT could induce the clearance of
aggregates via autophagy. We first transfected HEK293T cells
with GFP-tagged SOD1 or its aggregate-prone mutant, SOD1
(A4V), and also co-transfected the cells with mCherry-fused UXT
to determine colocalization. When observed under a fluorescence
microscope, WT SOD1 was diffused throughout the cytosol,
while SOD1(A4V) was mostly condensed in the form of one or
Fig. 1 A p62 binding protein, UXT colocalizes with protein aggregates. a Domain structure of p62. b p62 knockout HeLa cells (HeLa/p62KO) were
transiently transfected with FLAG-tagged p62 (wild type or ΔZZ–LB). Cells were treated with 5 µMMG132 for 6 h, and stained with anti-ubiquitin and anti-
p62 antibodies followed by anti-rabbit IgG-TRITC and anti-mouse IgG-Alexa-350 antibodies. DIC differential interference contrast images. Scale bar, 10
µm. c Clustering indexes (Supplementary Fig. 2) of p62 wild type or ΔZZ–LB mutant-transfected cells are calculated and represented as scatter plots (n=
82 and 101 cells examined over three independent experiments, mean ± SEM). ***p < 0.001 (two-sided Mann–Whitney test). d Yeast two-hybrid assays
showing the interaction between the ZZ–LB domain of p62 and UXT using LacZ, URA3, and ADE2 reporters. P and N, positive and negative control,
respectively. e HEK293T cells were transfected with HA-p62 and GFP-UXT, and their interaction was demonstrated by detection of GFP-UXT in
precipitates of HA-p62. f Proximity ligation assay (PLA) dots (red) representing close proximity of antibodies against p62 and UXT (right) were increased
compared to isotype control mouse and rabbit IgG antibodies (left). Nuclei were stained with DAPI (blue). Scale bar, 20 µm. g Number of PLA dots per
nucleus is shown as bar graphs (n= 6 and 7 random fields for each condition over three independent experiments, mean ± SEM). **p < 0.01 (two-sided
Mann–Whitney test). h Interaction between UXT and p62 deletion mutants was analyzed as in e. i Diagram of p62 LB domain-deletion mutants. j
Interactions between UXT and p62 mutants were analyzed as in e. k HeLa cells stably expressing GFP-CFTR(ΔF508) were treated with 2.5 µM MG132 for
12 h, and localization of the CFTR mutant and endogenous UXT (stained with anti-UXT antibody followed by anti-mouse IgG-Alexa-350) and p62 (stained
with anti-p62 antibody followed by anti-rabbit IgG-TRITC) were analyzed and compared to the untreated control. Scale bar, 25 µm. l Under the same
conditions used for k, the levels of UXT and p62 protein in the RIPA-insoluble fraction were analyzed. White and black arrowheads indicate LC3-I and -II,
respectively.
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two aggregates (Fig. 4a and Supplementary Fig. 3c). UXT showed
relatively dispersed punctate structures in control cells. However,
in the SOD1(A4V)-transfected cells, UXT showed a dense pattern
in close proximity to SOD1(A4V) aggregates (Fig. 4a and Sup-
plementary Fig. 3d). Consistent with this and previous
reports43–45, SOD1(A4V) was found in the detergent-insoluble
fraction of the cell lysate, and the amount of SOD1(A4V) protein
aggregates was significantly reduced in UXT co-transfected
cells (Fig. 4b, c). Inhibition of autophagy by bafilomycin A1
largely suppressed UXT-mediated reduction in detergent-
insoluble SOD1(A4V) aggregates (Fig. 4, c), suggesting that
UXT-dependent clearance of SOD1(A4V) aggregates occurred in
Fig. 2 UXT overexpression protects neuronal cells from proteasome inhibition-induced cell death. a Immunocytochemistry of dorsal root ganglion
(DRG) neurons. DRG neurons were treated with 2.5 µM MG132 for 12 h and compared to untreated controls. Endogenous p62 and ubiquitin-positive
protein aggregates (upper panels) or p62 and UXT (lower panels) were stained under both conditions with their specific primary antibodies, and
subsequently with anti-rabbit IgG-TRITC and anti-mouse IgG-Alexa-350 as secondary antibodies. Scale bar, 10 µm. b On day 0, DRG neurons (white
arrows) were isolated from day 13.5 mouse embryos and cultured for 48 h. On day 2, mCherry or mCherry-UXT was introduced into DRG neurons by
lentiviral transduction and cells were cultured for 2 days. On day 4, the DRG neurons were treated with 2.5 µM MG132 and observed under a live imaging
microscope with temperature and humidity control. DIC (differential interference contrast) images were collected for 28 h after MG132 treatment at 20
min intervals (Supplementary Movie 1). To identify the transduced cells, fluorescence images were also taken at the end. c DIC images collected at 0, 8, 18,
and 24 h and mCherry fluorescence images of DRG neurons are shown. Transduced cells are indicated with red asterisks. Membrane blebs are indicated
with arrowheads. Scale bar, 20 µm. d Survival of DRG neurons transduced with mCherry without MG132 treatment (blue), mCherry with MG132 treatment
(black), and mCherry-UXT with MG132 treatment (red) was analyzed and is shown with the number of DRG neurons analyzed. This analysis was repeated
twice with the essentially same results.
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Fig. 3 UXT and p62 cooperate and are involved in autophagy. a HeLa cells were treated with 2.5 μMMG132 and/or 50 nM bafilomycin A1 (Baf-A1) for 12
h, and the whole-cell lysates were subjected to a western blot analysis. b Band intensities of UXT in each condition were normalized to that of GAPDH, and
their relative intensities against non-treated condition are shown as bar graphs (n= 3, mean ± SEM). *p < 0.05; **p < 0.01; ***p < 0.001 (one-way ANOVA
using Bonferroni’s multiple comparison test). c HeLa cells were transfected with p62-siRNA and then whole-cell lysates were subjected to a western blot
analysis. d HeLa cells stably expressing GFP-LC3 were starved of amino acids using EBSS media, and this was followed by inhibition of the autophagic flux
by treatment with 50 nM Baf-A1 for 4 h. The localization of GFP-LC3 (green), p62 (blue), and UXT (red) were analyzed by immunocytochemistry, using
anti-p62 and anti-UXT as primary antibodies, and anti-rabbit IgG-Alexa-350 and anti-mouse IgG-TRITC as secondary antibodies. Scale bar, 10 μm.
e Pearson’s correlation coefficients between each protein were shown as scatter plots (n= 12 and 34 cells for control and EBSS+ Baf-A1, respectively,
mean ± SEM). ***p < 0.001 (two-sided Mann–Whitney test). f UXT-eYFP-10×His construct was transfected into HEK293E cells, and the protein purified
using a Ni-NTA column was treated with His-tagged HRV3C protease to cleave the region between UXT and eYFP. Resulting reaction was passed through
the second Ni-NTA column and further separated by size-exclusion chromatography (SEC). g Coomassie blue-stained SDS–PAGE gel profile of UXT-
containing SEC fractions in f is shown. Arrowhead indicates UXT. h The SEC fractions were further analyzed with western blot using anti-UXT, anti-p62,
and anti-LC3 antibodies.
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Fig. 4 UXT mediates the clearance of SOD1(A4V) aggregates by autophagy. a HEK293T cells were transiently transfected with SOD1 (wild type or
A4V)-GFP and mCherry-UXT or mCherry-only control. Representative images of transfected cells, merged composites and differential interference
contrast (DIC) images are shown. Scale bar, 10 μm. b HEK293T cells were transiently transfected with SOD1(A4V)-GFP and HA-UXT or vector, and were
treated with 50 nM bafilomycin A1 (Baf-A1) for 12 h, as shown. SOD1 and UXT were detected by western blotting in the detergent-insoluble fraction. LC3 in
whole-cell lysates were analyzed to confirm inhibition of autophagic flux by Baf-A1, and GAPDH was used as an internal loading control. c Band intensities
of SOD1(A4V)-GFP in detergent-insoluble fractions were normalized against those of HA-UXT-transfected cells without Baf-A1 treatment, and are shown
as bar graphs (n= 5, mean ± SEM). *p < 0.05; **p < 0.01; ns not significant (one-way ANOVA using Bonferroni’s multiple comparison test). d Immediately
after HEK293T cells were transiently co-transfected with SOD1(A4V)-GFP and mCherry-UXT or mCherry-only control, the cells were either treated with
50 nM bafilomycin or DMSO as a control, and fluorescence images of SOD1(A4V)-GFP in mCherry-positive cells were captured at 15 min intervals for
24 h. Representative images at 11, 15, 18, and 22 h are shown. Black and white images indicating pixels automatically recognized as aggregate regions by an
in-house MATLAB code (Supplementary Code 1) are also shown. Scale bar, 10 µm. e Averages of the aggregation indexes of cells in d that were vector
control transfected (gray, n= 10), mCherry-UXT transfected (blue, n= 11), and mCherry-UXT transfected along with bafilomycin A1 (Baf-A1) treatment
(yellow, n= 17) are shown. Mean ± SEM is indicated.
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an autophagy-dependent manner. To better understand the role
of UXT in protein degradation, we monitored expression and
aggregates formation in HEK293T cells transfected with GFP-
tagged SOD1(A4V), using a live cell imaging system (illustrated
in Fig. 2b). SOD1(A4V) aggregated initially in the form of several
small clusters that eventually coalesced to form dense aggregates
(Supplementary Movie 2). However, in UXT-transfected cells,
SOD1(A4V) did not form such dense aggregates, and growing
aggregates quickly disappeared. Notably, the inhibition of
autophagy by bafilomycin A1 negated this effect of UXT. For
quantification, similar to the method used for p62 body analysis,
we considered pixels with GFP fluorescence intensities exceeding
three standard deviations of the mean of whole-cell intensity as
regions of SOD1(A4V) aggregates (Fig. 4d), and calculated an
aggregation index by summing up the fluorescence intensity of
pixels in the regions of aggregates and divided it by the mean GFP
fluorescence intensity of the whole cell. Our quantification also
showed that the aggregation index gradually increased in control
cells, but not in UXT-transfected cells, and that bafilomycin
A1 significantly suppressed the effect of UXT (Fig. 4e). Similarly,
biochemical analysis of SOD1(A4V) aggregates at different time
points showed UXT-dependent disappearance of the aggregates,
while bafilomycin A1 suppressed the effect of UXT expression
(Supplementary Fig. 3e, f). In addition, siRNA-mediated knock-
ing down endogenous UXT increased the SOD(A4V) aggregates
(Supplementary Fig. 3g). Expression of another chaperone,
HSP70, as a control did not reduce the aggregates as efficiently as
UXT (Supplementary Fig. 3h), and inhibition of its activity by a
potent HSP70 family inhibitor, VER-155008, did not block the
action of UXT (Supplementary Fig. 3i). Taken together, these
results show that UXT mediates the clearance of protein aggre-
gates by autophagy, although we do not exclude the possibility
that UXT can also act as a chaperone refolding misfolded proteins
in a context-dependent manner.
UXT binding to the p62 LB domain enhances p62 body for-
mation. We next investigated how UXT might enhance autophagy.
In HeLa/p62KO cells, SOD1(A4V) aggregates cannot be formed
(Supplementary Fig. 4a), whereas transfection of WT p62 induced
SOD1(A4V)-positive p62 body formation as evidenced by both
ubiquitin antibody staining and GFP fluorescence from SOD1
(A4V) (Fig. 5a). The mutant p62(ΔLB) with disrupted UXT binding
(Fig. 1h) exhibited significantly reduced SOD1(A4V)-positive p62
body formation when transiently transfected (Fig. 5a, b), as well as
stably introduced (Supplementary Figs. 2e, f and 4b, c) into HeLa/
p62 KO cells, suggesting that LB domain removal may affect
intramolecular and/or intermolecular interactions for p62 body
formation. Because the LB domain was identified as the UXT-
binding site, we assumed that UXT–p62 interaction might be one of
such interactions needed for efficient p62 body formation. Indeed,
in HEK293T cells, overexpression of UXT also increased the tar-
geting of p62 to the detergent-insoluble aggregates fraction (Fig. 5c).
In contrast, there was reduced targeting of p62(ΔLB) to the inso-
luble fraction, and this was unaffected by UXT co-expression
(Fig. 5c, d). This showed that interaction between p62 and UXT
enhances the targeting of p62 to protein aggregates.
UXT is similar in structure to the hexameric chaperone,
prefoldin, and is thought to form oligomers46. As such, we
hypothesized that UXT may form oligomers that can crosslink
protein aggregates and p62 proteins, thereby promoting efficient
p62 body formation. To get a clue on this, we used an analytic
SEC column to analyze the elution profile of GFP-UXT in
detergent-free HEK293T cell lysates (Fig. 5e). There were two
major peaks observed (Fig. 5f). While the first peak near the void
column volume, possibly containing UXT binders, was observed
as in the SEC analysis during purification of UXT (Fig. 3f), the
second peak between 440 and 158 kDa was specifically observed
in this setting only (Fig. 5f). It may be due to the increased
stability of the complex appeared as the second peak in this
detergent-free condition and/or the selective detection of GFP-
UXT fluorescence in the analytic SEC column instead of the
nonspecific detection of protein concentration. The peak
corresponding to the size of the monomeric form of GFP-UXT
(~40 kDa) was negligible (Fig. 5f). Similarly, when UXT expressed
in HEK293T cells without any protein tagging was analyzed in a
native gel, it was detected as a possibly large aggregates stuck on
the well and also at near 250 kDa marker (Supplementary Fig. 4e,
empty and filled triangles), which may correspond to the first and
second peaks in the analytic SEC column. Addition of SDS to the
samples resulted in its predominant detection at its own size (~15
kDa; Supplementary Fig. 4e). Considering the monodispersity of
the peak and the band from overexpressed UXT observed near
250 kDa in the native conditions, it can be assumed that UXT
may form an oligomer, although the ~250 kDa complex can be
also generated by UXT’s interaction with other abundant
proteins. To determine the importance of UXT’s possible
oligomerization with respect to p62 function, we transiently
expressed an oligomerization-defective p62 mutant, p62(ΔPB1),
in HeLa/p62KO cells and studied its effect on p62 body
formation. Consistent with previous reports47, p62(ΔPB1) did
not form p62 bodies and was instead diffused throughout the
cytoplasm. In contrast, when mCherry-UXT was transiently co-
expressed with p62(ΔPB1), the mutant p62 was observed to form
clusters of aggregate structures that colocalized with UXT
(Fig. 5g). Although the aggregates showed relatively large and
irregular shapes presumably due to the absence of the PB1
domain per se and/or the PB1 domain-mediated oligomerization,
the complex seems to be degraded by autophagy because these
proteins in detergent-insoluble fraction were increased by
blocking autophagy (Supplementary Fig. 4f). To minimize
possible artifacts from too much modification on those proteins,
we also used an UXT with a smaller tag (HA-UXT) and an
oligomerization-defective p62 point mutant, p62(K7A/D69A)18.
In the experiment as well, we observed the similar UXT-
dependent oligomerization of p62(K7A/D69A) (Supplementary
Fig. 4g, h). These results suggest that UXT may exist as oligomer
that can enhance p62 body formation through direct interaction
with p62 and increase its avidity toward protein aggregates.
UXT binding to p62 is essential for its function with respect to
clearance of protein aggregates. To further validate the impor-
tance of the interaction between UXT and p62, we sought to
specifically disrupt this interaction. Previous reports have shown
that a proline substitution at Leu50 and Leu59 residues that are
highly conserved in vertebrates (Supplementary Fig. 5a) resulted
in the loss of additional UXT functions, such as regulating notch
signaling48 or as a centrosome component46. We thus adapted
the double L50P/L59P mutation and tested the effect of the
mutation on UXT functions, such as p62 binding (Fig. 1e), p62
clustering by p62(ΔPB1) (Fig. 5g), aggregates clearance (Fig. 4b),
and SEC profile (Fig. 5f). As the cyclic side chain of proline
usually induces a relatively large structural change, we also gen-
erated a UXT mutant that contained alanine substitutions at the
leucine residues, UXT(L50A/L59A). Co-immunoprecipitation
assays showed that both mutants had significantly decreased
p62 binding (Fig. 6a), although the L50P/L59P mutation is more
severe than the L50A/L59A mutation (Supplementary Fig. 5b, c).
Consistently, both mutants showed defects in enhancing p62
body formation of the clustering-defective mutant p62(ΔPB1)
(Fig. 6b, c, blue). Interestingly, we also found that UXT(L50A/
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L59A) showed punctate staining similar to the WT, but UXT
(L50P/L59P) was completely diffused throughout the cytoplasm
(Fig. 6, c, red), suggesting that the L50A/L59A mutant but not the
L50P/L50P mutant retains the aggregate-targeting function in
spite of the defects in p62 binding. We also found that both
mutants failed to decrease the formation of detergent-insoluble
SOD1(A4V) aggregates (Fig. 6d, top panel), thereby highlighting
the importance of p62 binding in this process. Consistent with
our imaging results, targeting of L50A/L59A mutant to the
detergent-insoluble fraction was essentially same with WT UXT
(Fig. 6d, middle panel), suggesting its aggregate-targeting ability is
independent of p62 binding. However, no L50P/L59P mutant was
observed in the detergent-insoluble fraction. Importantly, differ-
ences were also observed in their SEC profiles. L50A/L59A
showed an elution profile identical to that of the WT (compare
Figs. 5f and 6f, analyzed simultaneously), but L50P/L59P showed
clearly different pattern from WT (Fig. 6f), suggesting that its
complex-forming and/or oligomerization activity may be largely
reduced. Together, these results show that even with normal
aggregate-targeting and oligomerization function, defects in p62
binding observed with the L50A/L59A mutant can reduce p62
body formation and clearance of SOD1(A4V) aggregates. These
results also show that the L50A/L59A, but not the L50P/L59P
mutation can be used to specifically disrupt the interaction of
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UXT with p62, without affecting its aggregate-targeting and oli-
gomerization abilities.
UXT prevents SOD1(A4V)-induced progressive loss of motor
function in Xenopus. The results above suggest that UXT pro-
tects the cells from toxic protein aggregates. SOD1(A4V) and
SOD1(G93A) are the common toxic gain-of-function mutations
commonly associated with in the familial form of ALS, which is
clinically characterized by the progressive loss of motor neurons
and their function45. Expression of mutant human SOD1 in
animals also induces the formation of protein aggregates and
degeneration of motor neurons, and is widely used as a model of
ALS7,43,49,50. As Xenopus tropicalis develops rapidly and expres-
ses evolutionarily conserved UXT, SOD1, and p62 proteins
(Supplementary Figs. 5a and 6a, b), we used X. tropicalis as a
model to determine if the interaction between UXT and p62
inhibits the formation of toxic aggregates by pathogenic SOD1
mutants. First, we expressed GFP-tagged mutant SOD1 proteins,
SOD1(A4V) and SOD1(G93A), in the central nervous system by
targeted microinjection of in vitro-transcribed capped RNA
(Fig. 7a), and used the touch-induced escape responses, normal,
reduced, and no responses, as readouts of progressive loss of
motor ability (Fig. 7b and Supplementary Movie 3). Tadpoles
expressing SOD1 mutant genes did not show any apparent signs
of developmental defects and appeared normal (Fig. 7c). At stage
28, the early swimming state when muscle contract begins to be
coordinated, all tadpoles in all groups rapidly swam to the wall of
the well and circled around the circumference within second
(Fig. 7d). We performed the same test with the same animals
injected with SOD1(A4V) 2 days later, at stage 43, to observe any
possible deterioration in motor function with time (Supplemen-
tary Movie 4). In contrast to the control tadpoles, which showed
the same rapid escape responses, most SOD1(A4V)-expressing
tadpoles could not swim to the wall (reduced response, 16 out of
34) or could not swim at all (no response, 8 out of 34; Fig. 7e). As
the responses of the same tadpoles at stage 28 and at stage 43
were recorded, we concluded that expression of pathogenic
mutant SOD1 results in an age-dependent loss of fully developed
motor function in Xenopus. All tadpoles showed normal function
of the cardiac muscle, as such, this defect occurs first in skeletal
muscle (Supplementary Movie 5).
Then, we asked whether co-expressing UXT ameliorates SOD1
(A4V)-induced progressive loss of motor function. Before the
experiment, we confirmed the interaction between Xenopus p62
and human UXT by reciprocal co-immunoprecipitation assays
(Supplementary Fig. 7a). Expression of human UXT in Xenopus
almost completely ameliorated SOD1(A4V)-induced loss of
motor function (Fig. 7d, e). Importantly, the L50A/L59A mutant,
which cannot bind to p62, did not exhibit significant protective
effects (Fig. 7d, e), indicating that UXT prevents SOD1(A4V)-
induced loss of motor function through its interaction with p62.
Similarly, SOD1(G93A) expression produced a similar but milder
dysfunction of motor neurons and UXT suppressed the defect
(Fig. 7f, g). To further confirm the involvement of p62 in the
UXT-dependent protective effect, we microinjected a translation-
blocking antisense morpholino to inhibit the expression of the
endogenous p62. Blocking p62 expression did not induce any
morphological change (Supplementary Fig. 7b) nor significant
defect in motor function at stage 43 (Supplementary Fig. 7c),
when the most of behavioral assays in this study were performed,
although tadpoles gradually displayed compromised motor ability
at stages 44 and 45 (Fig. 7h). However, knocking down p62
almost completely blocked the UXT’s protective effect on SOD1
(A4V)-induced toxicity (Fig. 7I, j). These results suggest that
overexpression of human UXT may promote the clearance of
toxic SOD1(A4V) aggregates by autophagy in a p62-dependent
manner, thereby preventing loss of motor function. To test this
hypothesis, we examined the subcellular localization of SOD1
(A4V)-GFP in the spinal motor neurons of presymptomatic (i.e.,
stage 28) and symptomatic (i.e., stage 43) tadpoles (Fig. 7k).
Indeed, SOD1(A4V)-GFP was diffused throughout the cell at
stage 28, when no motor defects were observed, and had
aggregated at stage 43, when deterioration in motor function
was apparent. In addition, consistent with this hypothesis,
expression of UXT, but not UXT(L50A/L59A), inhibited the
accumulation of SOD1(A4V)-GFP aggregates completely at stage
43 (0 cells with aggregates out of 38 transfected cells; Fig. 7k).
Loss of UXT deteriorates proteotoxicity in Xenopus. Next, we
focused on the role of endogenous UXT in Xenopus. We first
confirmed the existence of endogenous UXT mRNA in whole
tadpole and spinal cord tissue at stages 30 and 43, using RT-PCR
(Fig. 8a) and in situ hybridization (Fig. 8b). Injection of UXT
morpholino into four blastomeres at eight cells stage caused a
dose-dependent defect in gross morphology, including a short and
bent trunk, a curly tail, a smaller yolk sac, and less pigment
(Fig. 8c), and those defects were recovered by co-injection of the
morpholino-resistant UXT mutant (Supplementary Fig. 7d),
confirming specificity of this phenotype. At the dose of 0.5 ng per
blastomere, roughly 40% of tadpoles showed no apparent mor-
phological defects (Fig. 8c), and all these tadpoles gained and
maintained full motor function. We asked whether these normally
developed UXT hypomorphic tadpoles may have a masked phe-
notype, such as inability to cope with proteotoxic challenges.
Expressing SOD1 mutants, A4V or G93A, which results in age-
dependent degeneration of motor function in WT tadpoles, was
lethal to these normal-looking tadpoles where endogenous UXT
expression was partially knocked down, suggesting that endo-
genous UXT protein is required to overcome proteotoxicity. To
test this idea further, we introduced a manageable proteotoxic
Fig. 5 UXT induces p62 clustering. a HeLa/p62KO cells were co-transfected with SOD1(A4V)-GFP and either FLAG-tagged p62 wild type or a p62(ΔLB)
mutant defective for UXT binding. After transfection, cells were treated with 5 μMMG132 for 6 h to induce p62 body formation and were stained with anti-
p62 and anti-ubiquitin antibodies followed by anti-mouse IgG-Alexa-350 and anti-rabbit IgG-TRITC. Representative images are shown. Scale bar, 10 μm. b
Clustering indexes in cells expressing wild-type p62 or p62(ΔLB) mutant were analyzed and are shown as scatter plots (n= 42 and 65 cells examined over
three independent experiments, mean ± SEM). ***p < 0.001 (two-sided Mann–Whitney test). c HEK293T cells were transiently co-transfected with FLAG-
tagged p62 (wild type or ΔLB mutant) and HA-UXT or vector control. The detergent-insoluble fraction of cell lysate was analyzed for the presence of these
proteins by western blotting. d The degree of p62 wild type and p62(ΔLB) mutant detected in the detergent-insoluble fraction was normalized against the
degree of their expression (whole-cell lysates) in each condition, and are shown as bar graphs (n= 3, mean ± SEM). *p < 0.05; **p < 0.01; ns not significant
(two-sided unpaired t test). e To detect an oligomeric form of UXT, detergent-free cell lysates of HEK293T cells expressing GFP-UXT were prepared and
their components were separated using a size-exclusion column (SEC) with a fluorometer. f SEC profile of GFP-UXT represented by GFP fluorescence of
eluant. Molecular weights of the marker are indicated. g HeLa/p62KO cells were transiently co-transfected with FLAG-p62(ΔPB1) mutant, the
oligomerization-defective mutant, and mCherry-UXT or mCherry-only control. The cells were stained with anti-p62 followed by anti-mouse IgG-Alexa-
350, and representative images are shown. p62(ΔPB1) clusters induced by UXT are indicated with white arrows. Scale bar, 10 μm.
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stress by overexpressing the WT SOD1 protein, which has little
effect in motor function development and maintenance in WT
tadpoles (Supplementary Fig. 7e). Indeed, overexpressing WT
SOD1 protein in the UXT hypomorphic tadpoles caused motor
function deterioration in almost all animals tested, in sharp
contrast to the WT tadpoles (Fig. 8d, e). In conclusion, our
results show that UXT, through its interaction with p62,
reduces the formation of toxic mutant SOD1 protein aggregates,
thereby preventing the progressive loss of motor function in
Xenopus.
Fig. 6 L50A/L59A mutations in UXT specifically disrupt interaction between p62 and UXT. a Interactions between p62 and UXT(L50P/L59P),
represented as L/P (upper panel) and p62 and UXT(L50A/L59A), represented as L/A (lower panel) were analyzed. b HeLa/p62KO cells were co-
transfected with oligomerization-defective p62(ΔPB1) and either UXT wild type, UXT(L50A/L59A), or UXT(L50P/L59P) mutants, and were stained with
anti-p62 antibody followed by anti-mouse IgG-Alexa-350. Representative images are shown. p62(ΔPB1) clusters induced by UXT are indicated with white
arrows. Scale bar, 10 μm. c Clustering indexes of p62 (left) and UXT (right) were analyzed under each condition, and are shown as scatter plots (n= 98,
82, and 22 cells examined over three independent experiment, mean ± SEM). ***p < 0.001; ns not significant (two-sided Mann–Whitney test). d The effects
of L50P/L59P and L50A/L59A UXT mutations on the amount of detergent-insoluble SOD1(A4V) aggregates. e The degree of HA-UXT mutants detected
in the detergent-insoluble faction was normalized against that of HA-UXT wild type and shown as bar graphs (n= 3, mean ± SEM). ***p < 0.001; ns not
significant (one-way ANOVA using Bonferroni’s multiple comparison test). f SEC profiles of GFP-UXT(L50A/L59A) and GFP-UXT(L50P/L59P) as
detected by GFP fluorescence in the eluant.
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Discussion
The process of selective degradation of protein aggregates by
autophagy, aggrephagy, requires so-called autophagy receptors,
such as p62, NBR1 (ref. 51), and optineurin52, working as a
molecular bridge between ubiquitinated substrates and LC3/
GABARAP family proteins anchoring on the phagophore53.
Their function can be further enhanced by adaptor proteins that
link the aggregates to core autophagic machinery54. ALFY, a
known autophagy adaptor, binds to p62, ATG5, and phosphati-
dylinositol 3-phosphate (PI3P) on the phagophore
membrane55,56. Because ATG5 is the key component for con-
jugation of PE with LC3 (ref. 57), ALFY can recruit p62 bodies
Fig. 7 UXT prevents SOD1(A4V)-induced progressive loss of motor ability in Xenopus. a SOD1 and/or UXT in vitro-transcribed capped RNA were
expressed in the central nervous system by targeted microinjection. Motor function was assessed by touch-induced swimming responses at stages 28 and
4. b Each tadpole was touched three times on its tail. Each trace in a circle indicates swimming trajectory of the same tadpole within 3 s (time after the
touch is color-coded). The best response of three trials was used to classify the swimming ability. c Injecting SOD1 mutant genes did not result in
distinguishable morphological changes. Scale bar, 2 mm. d Swimming responses of tadpoles injected with SOD1 mutant and/or UXT (wild type or L50A/
L59A mutant) in vitro-transcribed capped RNA are shown. The behavior of tadpoles was recorded in three independent experiments. The Y-axis indicates
the percentage of tadpoles showing a normal swimming response, and the X-axis indicates developmental stages. e Quantification of d at stage 43 with the
number of tadpoles in each category is shown. Cyan, yellow, and orange bars represent normal, reduced, and no swimming responses, respectively. The Y-
axis indicates the percentage of tadpoles. Ctl control; ***p < 0.001 (two-sided Fisher’s exact test). f, g Effect of UXT expression on SOD1(G93A)-GFP-
induced motor deficit was tested as in d and e. +p= 0.0968; **p < 0.01 (two-sided Fisher’s exact test). h, i Effect of a p62 translation-blocking antisense
morpholino (MO) on swimming responses was analyzed as in d and e. j Quantification of i at stage 43 as in e. ***p < 0.001 (two-sided Fisher’s exact tests).
ns not significant. k SOD1(A4V)-GFP was visualized by immunohistochemistry in cell bodies of lower motor neurons localized in the ventral horn of the
spinal cord. Red and green arrows indicate SOD1(A4V)-GFP aggregation and SOD1(A4V)-GFP, respectively. Co-injecting UXT completely prevents SOD1
(A4V)-GFP aggregation indicated by white arrows. In cells co-injected with UXT(L50A/L59A (L/A)), the SOD1(A4V)-GFP aggregation is often observed
as indicated by yellow arrows. Numbers in parenthesis indicate the number of cells with aggregation/the number of transfected cells analyzed. Scale
bar, 10 µm.
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near the PI3P-containing phagophore where it induces the for-
mation of PE-conjugated LC3, thus facilitating the p62-
dependent autophagy. In our attempt to find such autophagy
adaptors, we identified UXT as a p62 binder and demonstrated
that their interaction can prevent proteotoxicity by facilitating
autophagic degradation of protein aggregates.
In accordance with our hypothesis that autophagic clearance of
toxic aggregates involving UXT–p62 interaction is required for
maintenance of motor neuronal health and function, missense
mutations in p62 are indeed linked to ALS in human58, and p62
loss-of-function exacerbates motor neuron degeneration in ALS
models in mouse59 and zebrafish60. In case of UXT, there are no
known mutations associated with neurodegenerative diseases,
presumably because functionally harmful mutations in UXT may
be lethal as in the Xenopus study, where its knockdown leads to
severe developmental defects (Fig. 8c and Supplementary Fig. 7d).
Intriguingly, both UXT61 and p62 (ref. 59) are known to interact
with als2 protein, associated with ALS in human.
Then, how does UXT enhance the autophagy function of p62?
p62 is a multi-domain protein that functions as a receptor that
links protein aggregates to the autophagy machinery15. The N-
terminal PB1 domain mediates homo-oligomerization of p62,
which can increase its affinity for protein aggregates and/or the
phagophores15,18,19, is also crucial for p62 function. Indeed,
deletions or mutations in the PB1 domain reduce LC3 binding
and p62 body formation18,62, illustrating the importance of
higher-order oligomer formation of p62 with respect to its
function in autophagy. Similarly, the oligomerization of an
autophagy receptor in yeast, Cue5, is also known to play a role in
targeting the protein aggregates for autophagy63. Structural stu-
dies have shown that the PB1 domain forms long filamentous
helical polymers though successive electrostatic interactions19. As
the polymerization mainly depends on interactions between the
acidic and basic surfaces on the two opposite faces of PB1 domain
in a head-to-tail manner, the polymerization leads to a linear
polymer without branching. Moreover, the linear p62 polymer
forms a helical structure with PB1 domains closely packed inside
of the helix19. In this highly packed helical structure of p62
polymer, bending of the polymers would not be favored due to
the steric hindrance from each molecule in the structure, thus
limiting its degree of freedom and efficiency of binding to protein
aggregates and LC3. As UXT is expected to form an oligomer that
can provide multiple binding sites for p62, interactions between
the p62 filament and oligomeric UXT may possibly circumvent
this limitation by weaving the filamentous p62 polymers to create
a reticulated p62 structure that can serve as a high-affinity trap
for ubiquitinated protein aggregates and LC3 (Supplementary
Fig. 8b). This may explain the ability of UXT to enhance the
function of p62 in autophagy.
Second, the chaperone function of UXT may also enhance p62-
dependent autophagy through the ubiquitin-independent
recruitment of p62 to protein aggregates. UXT belongs to a
prefoldin α-like family that along with the prefoldin β family,
forms a hetero-hexameric jellyfish-like molecular chaperone
complex31,64. If UXT can form a similar oligomeric structure as
prefoldin, the internal surface of the UXT in the structure would
interact with unfolded protein (Supplementary Fig. 8c). We
observed that UXT can be localized in the detergent-insoluble
Fig. 8 UXT is required in coping with proteotoxicity in Xenopus. a Reverse transcription-PCR of UXT mRNA in whole tadpole and spinal cord tissue. The
entire coding sequence of UXT mRNA was amplified with a band of 460 bp. b In situ hybridization of UXT mRNA (left) and immunohistochemistry of
acetylated tubulin (right). The green arrow indicates a lower motor neuronal cell body and the yellow arrows indicate the axons of these neurons. Scale bar,
10 µm. c UXT morpholino (MO) was injected to four blastomeres at the eight cells stage. The injected tadpoles showed a dose-dependent defect in gross
morphology in contrast to the control group. The numbers indicate the number of embryos with the same morphology as the representative image out of
all examined embryos. Scale bar, 1 mm. d Tadpoles injected with 0.5 ng of control or UXT MO together with wild-type SOD1, but showing normal
morphology were analyzed for their motor ability as in Fig. 7d. In three independent experiments, each with the full set of groups, the behaviors of 19, 20,
19, and 28 tadpoles were recorded for control, SOD1 WT, UXT MO, and UXT MO+ SOD1 WT group, respectively. St stage. e Quantification of d at stage
43. Cyan, yellow, and orange bars indicate normal, reduced, and no swimming responses, respectively. Ctl control. ***p < 0.001 (two-sided Fisher’s exact
tests).
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fraction normally even when p62 binding is impaired by the
L50A/L59A mutation (Fig. 6d), showing that UXT can interact
with unfolded proteins and recruit p62 to aggregates independent
of its ability to interact with ubiquitinated target proteins. In fact,
several ubiquitin-independent- and chaperone-mediated selective
autophagy (CMA) mechanisms, e.g., aided by the aggregates
targeted heat-shock protein and its co-chaperone BAG3, have
been identified65,66. A distinct feature of CMA is the direct
delivery of misfolded proteins by chaperones to the lysosome,
where specific lysosomal membrane proteins translocate the
misfolded protein into the lysosomal lumen without the invol-
vement of phagophores67. As UXT colocalizes with LC3, a marker
of the growing phagophore, and as its protective function is
dependent on the interaction with p62 (Fig. 7i), the action of
UXT is distinct from that of CMA and appears to involve the
aggrephagy system. This suggests a role for chaperones in
aggrephagy.
In conclusion, we have identified UXT as an autophagy
adaptor that cooperates with p62 to enhance the removal of
protein aggregates by autophagy. Because increasing UXT protein
level could relieve the proteotoxicity (Figs. 2d and 7d, e), we
believe that our findings may provide a therapeutic strategy for
protein aggregation-mediated diseases, e.g., by a gene delivery of
UXT or by a selective inhibition of UPS-dependent degradation
of UXT (Fig. 3a). This study also creates a paradigm for coop-
eration by chaperones with the aggrephagy system to clear mis-
folded proteins.
Methods
Cell culture. HEK293T (ATCC), HeLa cells (ATCC), HeLa cells expressing GFP-
CFTR(ΔF508)37, p62 knockout HeLa cells (HeLa/p62KO; generated by CRISPR-
Cas9 system), HeLa cells expressing GFP-LC3 (HeLa/GFP-LC3; generated by
lentiviral transduction), and HeLa/p62KO cells expressing p62 WT or mutants
(generated by lentiviral transduction of GFP-tagged p62 constructs into HeLa/
p62KO cells) were maintained in Dulbecco’s modified Eagle’s medium (HyClone)
supplemented with 10% (v/v) fetal bovine serum (Gibco), and 1% penicillin–
streptomycin (HyClone) at 37 °C with 5% CO2 in an incubator. For the starvation
experiment, cells were incubated in EBSS (HyClone). DRG neurons were isolated
from E13.5 mouse embryos and cultured in neurobasal medium (Thermo Fisher)
supplemented with 1% penicillin–streptomycin (HyClone), 5-fluoro-2-
deoxyuridine (final concentration, 2.5 µg/mL; Sigma) and uridine (Sigma), 1×
B27 supplement (Thermo Fisher), GlutaMAX supplement (Thermo Fisher), and
Nerve Growth Factor 2.5 s (Life Technologies, 100 ng/mL) at 37 °C in an atmo-
sphere containing 5% CO2 in an incubator.
Plasmids and cloning. pcDNA3-HA-p62 was previously described68. pEGFP-n3-
SOD1 WT and mutants (A4V and G93A) were provided by S.M. Kang. pOTB7-
UXT clone (hMU006749) was obtained from the Korea Human Gene Bank,
Medical Genomics Research center, KRIBB, Korea. Plasmid constructs were gen-
erated using restriction enzyme digestion and cloning, and mutant constructs of
p62 or UXT were prepared by site-directed mutagenesis. HA-Xenopus p62 was
purchased from GenScript. The constructs, cloning methods, and sequences of
primers used are described in the Supplementary Data 1.
Antibodies. The following antibodies were used for immunoblotting (IB),
immunocytochemistry (ICC), immunoprecipitation (IP), and immunohistochem-
istry (IHC): mouse monoclonal anti-ubiquitin (1:200 (ICC), Abcam, ab7254),
rabbit monoclonal anti-ubiquitin (1:200 (ICC), Abcam, ab134953), mouse mono-
clonal anti-p62 (1:2000 (WB), 1:500 (ICC), Abcam, ab56416), rabbit monoclonal
anti-p62 (1:2000 (WB), 1:500 (ICC), Abcam, ab109012), rabbit polyclonal anti-p62
(2 µg (IP), Abcam, ab101266), mouse polyclonal anti-UXT (1:500 (IB), 1:200
(ICC), Abcam, ab168678), rabbit polyclonal anti-UXT (1:1000 (IB), Sigma,
AV51213), rabbit monoclonal anti-LC3A/B (1:1000 (IB), 1:200 (ICC), CST, 12741),
mouse monoclonal anti-GAPDH (1:2500 (IB), Santa Cruz, sc-32233), rabbit
polyclonal anti-cleaved Caspase-3 (Asp175) (1:300 (ICC), CST, 9661), rabbit
polyclonal anti-acetylated alpha Tubulin (acetyl K40) (1:300 (IHC), Abcam,
ab12536), mouse monoclonal anti-GFP (1:2500 (IB), 2 µg (IP), Santa Cruz, sc-
9996), mouse monoclonal anti-FLAG (1:2500 (IB), Sigma, F1804), rabbit poly-
clonal anti-HA (1:2000 (IB), 2 µg (IP), Thermo Fisher, 71-5500), normal mouse
IgG (1:500 (ICC), Santa Cruz, sc-2025) and normal rabbit IgG (1:500 (ICC), 2 µg
(IP), CST, 2729), goat anti-mouse-HRP conjugated (1:10000 (IB), Thermo Fisher,
31430), goat anti-rabbit-HRP conjugated (1:10000 (IB), Thermo Fisher, 31460),
anti-rabbit IgG-Alexa Fluor 350 (1:1000 (ICC), Thermo Fisher, A11046), anti-
mouse IgG-Alexa Fluor 350 (1:1000 (ICC), Thermo Fisher, A11068), anti-rabbit
IgG-Alexa 555 antibody (1:1000 (IHC), Thermo Fisher, A31572), anti-rabbit
IgG-TRITC (1:1000 (ICC), Jackson Laboratory, 711-025-152), and anti-mouse
IgG-TRITC (1:1000 (ICC), Jackson Laboratory, 715-025-151).
Yeast two-hybrid screening. Yeast two-hybrid screening of p62 was performed
using the yeast strain PBN204 that contained three reporters (URA, lacZ and
ADE2). Amino acids 114‒224 of p62 were cloned as an EcoRI/XhoI fragment into
EcoRI/SalI sites of a pGBKT vector. The pGBKT plasmid contained the cDNA
encoding the DNA-binding domain of GAL4 (GAL4 BD), a TRP1 selection mar-
ker, KanR marker and the replication origin sequence of yeast 2 µ plasmid. The
junction between GAL4 BD and the p62 was verified by DNA sequencing. Using a
cDNA library, human thymus cDNA inserts were cloned as EcoRI/XhoI fragments
into a pACT2-containing the cDNA encoding GAL4-activating domain. Yeast
transformants of the p62 bait and human thymus cDNA AD library were plated on
selection medium-leucine, tryptophan, and uracil. After selecting yeast colonies on
uracil-deficient media, the beta-galactosidase activity was monitored. The screened
URA+ and lacZ+ colonies were then tested for growth on adenosine-deficient
media. For this, three independent reporters with different types of GAL4-binding
sites were utilized to reduce the number of false positive candidates. To further
confirm the interaction, DNA isolated from the prey URA+ADE+LacZ+ candi-
dates was amplified by PCR or Escherichia coli transformation. The amplified
candidate prey DNA samples were reintroduced into yeast with the p62 bait
plasmid or with a negative control (vector) plasmid, and then the growth of yeast
transformants was studied.
p62 knockout using CRISPR/Cas9. p62 was knocked out in HeLa cells using the
GeCKO (Genome-scale CRISPR Knock-Out) system69 with two target sequences,
p62KO-1 (5′-CGGGTCCGGGACCCTGCGAGCGG-3′) and p62KO-2 (5′-TAGTG
CGCCTGGAAGCCGCCAGG-3′). CRISPR/Cas9-resistant p62 constructs con-
taining the silencing mutation in the 3′ three nucleotides of the target sequences
(PAM sequence) were used for p62 expression in HeLa/p62KO cells.
Co-immunoprecipitation. Polyethylenimine was used to transiently transfect
HEK293T cells, and the cells and constructs were incubated at 37 °C for 24 h. Cells
were lysed with lysis buffer containing 20 mM HEPES, pH 7.4; 150 mM NaCl; 1%
NP-40; 1 mM EDTA; and protease inhibitor cocktail (Roche). After centrifugation
for 20 min at 17,000 × g, the resulting supernatants were incubated with antibodies
for 4 h at 4 °C, following which they were incubated overnight with protein A or G
agarose beads (Pierce) at 4 °C. The pellets were washed four times with lysis buffer
and proteins were analyzed by IB.
Quantitative RT-PCR. Total RNA was extracted using TRIzol (Thermo), and
mRNA was reverse transcribed into cDNA using the PrimeScript RT reagent kit
(Takara). Quantitative RT-PCR was performed using a LightCycler 2.0 (Roche),
with a LightCycler 480 SYBR Green I Master kit (Roche) and specific primers. The
sequences of primers used are listed in the Supplementary Data 1. Expression levels
of UXT were normalized to those of actin mRNA. The relative amount of mRNA
expression was calculated by using the ΔΔCt method.
Preparation of the detergent-insoluble fraction. Cells were lysed with lysis
buffer A containing 20 mM HEPES, pH 7.4; 150 mM NaCl; 1% Triton X-100;
1 mM EDTA; and protease inhibitor cocktail (Roche). Five percent of the resulting
lysate was saved as total protein. After centrifugation at 17,000 × g (4 °C for 20 min)
the supernatant, or the detergent-soluble fraction, was removed. The pellet, or the
detergent-insoluble fraction, was washed with lysis buffer A and solubilized with
lysis buffer B containing 20 mM HEPES, pH 7.4; 150 mM NaCl; 1% Triton X-100;
1% SDS; 1 mM EDTA; and protease inhibitor (Roche). A total of 15–20 μg of
proteins were loaded per sample. Uncropped scans of blots are supplied in the
Source data file.
Immunocytochemistry. Lipofectamine 2000 (Invitrogen) was used to transfect
cells cultured on gelatin-coated coverslips with various constructs. After transfec-
tion, cells were incubated for 24 h, following which, they were fixed using 3.7%
formaldehyde, and then permeabilized with phosphate-buffered saline (PBS)
containing 0.1% Triton X-100 (PBST). Cells were treated with the blocking solution
(1% BSA, 22.52 mg/mL glycine, and 0.1% gelatin in PBST), and were stained first
with respective primary antibodies and subsequently with fluorophore-conjugated
secondary antibodies diluted in blocking solution. Coverslips were mounted on
microscope slides with fluorescence mounting medium (Dako) with or without
Hoechst (Invitrogen). Images were acquired using a fluorescence microscope (Ti-E,
Nikon) equipped with a 100× (1.4 N.A) Plan-Apochromat objective lens and a
charge-coupled camera device (DS-Qi2, Nikon). The images were processed using
NIS-Elements AR (Nikon) and/or ImageJ (NIH) software. A PLA assay was per-
formed using a Duolink in situ red starter kit mouse/rabbit (Sigma-Aldrich,
DUO92101), according to manufacturer’s instructions.
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Xenopus experiments. X. tropicalis embryos were generated by in vitro fertilization,
raised in 0.1× Modified Barth’s Saline at 21–24 °C, and staged according to the tables
provided in Nieuwkoop and Faber (1967) and Xenbase (http://www.xenbase.org/).
The mMESSAGE mMACHINE kit (Ambion) was used to transcribe the capped
RNAs in vitro. Translation-blocking antisense morpholino oligonucleotides were
purchased from Gene Tools, LLC. The sequence information is in Supplementary
Data 1. A total of 450 pg (200 pg encoding EGFP-fused SOD1 mutants or control
(EGFP), 200 pg encoding UXT or control (mCherry), and 50 pg encoding a tracer
(mCherry)) of RNA per blastomere was microinjected into two dorsal blastomeres
that give rise to the central nervous system. A total of 0.5 or 1 ng of morpholino oligo
was injected, as described in the figure legends. One injected embryo was placed per
well in 24-well culture plates. Under a dissection microscope equipped with a video
camera, each tadpole was touched at least three times on its tail with the tip of a
plastic microloader. Response was classified as a normal response when the tadpole
swam to the edge of the well and then around the well within 3 s. Response was
classified as a reduced response when the distance that the tadpole swam was shorter
than the radius of the well. Response was classified as no response when the tadpole
failed to move forward at all. The best score of three consecutive tests was recorded
for each tadpole. Tadpoles were fixed overnight in 4% paraformaldehyde prepared in
PBS at 4 °C. The fixed embryos were sectioned using a cryostat, and imaged under a
LSM confocal microscope (Zeiss) equipped with a 63× C-Apochromat (numerical
aperture 1.2) objective, with a XY zoom factor of 1.50. All experiments complied
with protocols approved by the Yonsei University College of Medicine Institutional
Animal Care and Use Committees.
Statics and reproducibility. Statistical analysis was performed on data from three
or more biologically independent experiments using GraphPad Prism (v 9.0.0,
GraphPad Software). Statistical parameters including precise value of n (total
number of analyzed cells, microscopic fields, independently repeated experiments),
p values, definitions of error bars with a measure of center, and statistical tests used
are indicated in the figures and figure legends. All experiments were done three
times, unless otherwise stated.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The main data supporting this study are available within this article. All other data
supporting the findings of this study are available from the corresponding author upon
request. Source data are provided with this paper.
Code availability
The source code is provided as Supplementary Code 1 and available at https://doi.org/
10.5281/zenodo.4563694 (ref. 70) without restrictions. This work uses MATLAB (The
MathWorks Inc).
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